These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1825249)

  • 21. Effects of methylprednisolone on the in vitro induction of human secondary suppressor and cytotoxic lymphocytes.
    Pfeffer PF; Randazzo B; Hirschberg T; Hirschberg H
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1157-9. PubMed ID: 6455820
    [No Abstract]   [Full Text] [Related]  

  • 22. Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization.
    Brogan MD; Shanahan F; Oliver M; Stevens RH; Targan SR
    J Clin Lab Immunol; 1987 Oct; 24(2):69-74. PubMed ID: 3437440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective activation of antigen-specific human B cells in recently immunized individuals by nonspecific factors in the absence of antigen.
    Peters M; Fauci AS
    J Immunol; 1983 Feb; 130(2):678-80. PubMed ID: 6184400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen reactive memory T cells are defined by Ta1.
    Hafler DA; Fox DA; Benjamin D; Weiner HL
    J Immunol; 1986 Jul; 137(2):414-8. PubMed ID: 3013990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of dexamethasone on immunological memory to tetanus toxoid in sheep.
    Adams DB; Anderson BH; Lynch JJ; Munro RK
    Vet Immunol Immunopathol; 1997 Dec; 60(1-2):89-95. PubMed ID: 9533269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergy between lysosomotropic amines and cyclosporin A on human T cell responses to an exogenous protein antigen, tetanus toxoid.
    Schultz KR; Nelson D; Bader S
    Bone Marrow Transplant; 1996 Sep; 18(3):625-31. PubMed ID: 8879628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium.
    Lemster B; Woo J; Strednak J; Wang SC; Todo S; Starzl TE; Thomson AW
    Transplant Proc; 1992 Dec; 24(6):2845-6. PubMed ID: 1281576
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhancement of vaccine-specific cellular immunity in infants by passively acquired maternal antibody.
    Rowe J; Poolman JT; Macaubas C; Sly PD; Loh R; Holt PG
    Vaccine; 2004 Sep; 22(29-30):3986-92. PubMed ID: 15364448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related decline in the in vitro and in vivo syntheses of anti-tetanus toxoid antibody in humans.
    Kishimoto S; Tomino S; Mitsuya H; Fujiwara H; Tsuda H
    J Immunol; 1980 Nov; 125(5):2347-52. PubMed ID: 6968781
    [No Abstract]   [Full Text] [Related]  

  • 30. Substituted guanine ribonucleosides as B cell activators.
    Gupta S; Vayuvegula B; Gollapudi S
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 2):S21-7. PubMed ID: 1934610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RS-61443 reverses acute renal allograft rejection in dogs.
    Platz KP; Bechstein WO; Eckhoff DE; Hullett DA; Sollinger HW
    Transpl Int; 1992; 5 Suppl 1():S542-3. PubMed ID: 14621871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The selective role of membrane IgG in the antigen-induced inhibition of human in vitro antibody synthesis.
    Stevens RH; Benveniste E; Pineda E
    J Immunol; 1982 Jan; 128(1):398-401. PubMed ID: 6798112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of passive immunization against tetanus toxoid in man.
    Plassara M; Mandalenaki C; Papathanassiou E; Vrachnou E; Athanassiades P
    Immunology; 1978 Sep; 35(3):567-70. PubMed ID: 308931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of rituximab therapy on response to tetanus toxoid vaccination in kidney-transplant patients.
    Puissant-Lubrano B; Rostaing L; Kamar N; Abbal M; Fort M; Blancher A
    Exp Clin Transplant; 2010 Mar; 8(1):19-28. PubMed ID: 20199367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapamycin's long-term effects on humoral and cellular immune responses in the rat.
    Daloze P; Chen H; Luo H; Xu D; Shan X; Wu J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):721-2. PubMed ID: 8438456
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
    Jennings HJ; Roy R; Gamian A
    J Immunol; 1986 Sep; 137(5):1708-13. PubMed ID: 3091688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiotypic determinants on human T cells and modulation of human T cell responses by anti-idiotypic antibodies.
    Geha RS
    J Immunol; 1984 Oct; 133(4):1846-51. PubMed ID: 6206140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined standard and novel immunosuppressive substances affect B-lymphocyte function.
    Matz M; Lehnert M; Lorkowski C; Fabritius K; Weber UA; Mashreghi MF; Neumayer HH; Budde K
    Int Immunopharmacol; 2013 Apr; 15(4):718-25. PubMed ID: 23499640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary sensitisation and restimulation of human lymphocytes with soluble antigen in vitro.
    Hensen EJ; Elferink BG
    Nature; 1979 Jan; 277(5693):223-5. PubMed ID: 551249
    [No Abstract]   [Full Text] [Related]  

  • 40. Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation.
    Allison AC; Eugui EM
    Transplant Proc; 1994 Dec; 26(6):3205-10. PubMed ID: 7998117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.